BIA-ALCL is not breast cancer. Instead, it is a rare T-cell lymphoma that can develop following breast implants, according to the World Health Organization.
The major symptoms of BIA-ALCL include:
- Persistent swelling or pain in the area of the breast implant
- Fluid collection around the implant
- A noticeable mass or scar capsule around the implant
These symptoms may occur long after the surgical incision has healed, sometimes even years after the implant was originally positioned.
Just two years ago, only about 30 percent of plastic surgeons were discussing cancer risk with their breast implant patients.
However, because most of the confirmed cases of BIA-ALCL have occurred in those with textured implants, the FDA now recommends that health care professionals provide the manufacturer’s labeling as well as any other educational materials to potential breast implant patients before surgery, and discuss with them the risks and benefits associated with the various types of implants.
Research now points to the fact that breast implant complications such as this rare form of cancer should be avoidable.
